Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dutch pharmacogenetics working group (DPWG) guideline for the gene-drug interaction between UGT1A1 and irinotecan.
Hulshof EC, Deenen MJ, Nijenhuis M, Soree B, de Boer-Veger NJ, Buunk AM, Houwink EJF, Risselada A, Rongen GAPJM, van Schaik RHN, Touw DJ, van der Weide J, van Westrhenen R, Deneer VHM, Guchelaar HJ, Swen JJ. Hulshof EC, et al. Among authors: deenen mj. Eur J Hum Genet. 2023 Sep;31(9):982-987. doi: 10.1038/s41431-022-01243-2. Epub 2022 Nov 28. Eur J Hum Genet. 2023. PMID: 36443464 Review.
Identification of pharmacogenetic biomarkers for efficacy of cytoreductive surgery plus hyperthermic intraperitoneal mitomycin C in patients with colorectal peritoneal metastases.
Hulshof EC, Lurvink RJ, Caserta N, de Hingh IHJT, van Wezel T, Böhringer S, Swen JJ, Gelderblom H, Guchelaar HJ, Deenen MJ. Hulshof EC, et al. Among authors: deenen mj. Eur J Surg Oncol. 2020 Oct;46(10 Pt A):1925-1931. doi: 10.1016/j.ejso.2020.04.019. Epub 2020 Apr 15. Eur J Surg Oncol. 2020. PMID: 32354538
Genetic Variants in DNA Repair Pathways as Potential Biomarkers in Predicting Treatment Outcome of Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: A Systematic Review.
Hulshof EC, Lim L, de Hingh IHJT, Gelderblom H, Guchelaar HJ, Deenen MJ. Hulshof EC, et al. Among authors: deenen mj. Front Pharmacol. 2020 Oct 6;11:577968. doi: 10.3389/fphar.2020.577968. eCollection 2020. Front Pharmacol. 2020. PMID: 33117169 Free PMC article.
Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data.
van der Lee M, Allard WG, Vossen RHAM, Baak-Pablo RF, Menafra R, Deiman BALM, Deenen MJ, Neven P, Johansson I, Gastaldello S, Ingelman-Sundberg M, Guchelaar HJ, Swen JJ, Anvar SY. van der Lee M, et al. Among authors: deenen mj. Sci Transl Med. 2021 Jul 21;13(603):eabf3637. doi: 10.1126/scitranslmed.abf3637. Sci Transl Med. 2021. PMID: 34290055
UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients.
Hulshof EC, de With M, de Man FM, Creemers GJ, Deiman BALM, Swen JJ, Houterman S, Koolen SLW, Bins S, Thijs AMJ, Laven MMJ, Hövels AM, Luelmo SAC, Houtsma D, Shulman K, McLeod HL, van Schaik RHN, Guchelaar HJ, Mathijssen RHJ, Gelderblom H, Deenen MJ. Hulshof EC, et al. Among authors: deenen mj. Eur J Cancer. 2022 Feb;162:148-157. doi: 10.1016/j.ejca.2021.12.009. Epub 2022 Jan 5. Eur J Cancer. 2022. PMID: 34998046 Free article.
Response to letter entitled re: UGT1A1 genotype-guided dosing of irinotecan: A prospective safety and cost analysis in poor metaboliser patients: Is it time for everyone treated with irinotecan to be tested for UGT1A1 gene polymorphism?
Hulshof EC, de With M, Creemers GJ, Guchelaar HJ, Mathijssen RH, Gelderblom H, Deenen MJ. Hulshof EC, et al. Among authors: deenen mj. Eur J Cancer. 2022 Sep;172:231-233. doi: 10.1016/j.ejca.2022.05.045. Epub 2022 Jul 3. Eur J Cancer. 2022. PMID: 35793611 No abstract available.
Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between UGT1A1 and irinotecan.
Hulshof EC, Deenen MJ, Nijenhuis M, Soree B, de Boer-Veger NJ, Buunk AM, Houwink EJF, Risselada A, Rongen GAPJM, van Schaik RHN, Touw DJ, van der Weide J, van Westrhenen R, Deneer VHM, Guchelaar HJ, Swen JJ. Hulshof EC, et al. Among authors: deenen mj. Eur J Hum Genet. 2023 Sep;31(9):1088-1089. doi: 10.1038/s41431-023-01315-x. Eur J Hum Genet. 2023. PMID: 36797469 Free article. No abstract available.
64 results